KCclean Posted - 1 week ago

$PBH ya, that makes sense

Pika_Capital Posted - 2 weeks ago

$PRGO $PBH $IBRX $APLS anyone who tags MYNZ, report them viciously. Bots took over X platform. Hopefully ST will stop this nonsense. @Alyssa_CC

DonCorleone77 Posted - 2 weeks ago

$PBH Prestige Consumer backs FY25 adjusted EPS view $4.40-$4.46, consensus $4.74 Backs FY25 revenue view $1.125B-$1.14B, consensus $1.16B. Sees FY25 free cash flow $240M or more.

DonCorleone77 Posted - 2 weeks ago

$PBH Prestige Consumer reports Q2 EPS $1.09, consensus $1.08 Reports Q2 revenue $283.8M, consensus $282.09M. "Our second quarter results exceeded our sales and earnings expectations thanks to the strength of our diverse portfolio of market-leading brands and the benefits of our disciplined capital deployment strategy. Second quarter revenues were stronger than expected, primarily due to solid growth in our International and Canadian businesses, which largely offset Clear Eyes supply constraints. In addition, strong double-digit free cash flow growth enabled us to repurchase additional shares in the second quarter and continue reducing debt and leverage," said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.

Estimize Posted - 2 weeks ago

$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act

StockLight375 Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $PBH $IBRX

Estimize Posted - 10/28/24

Wall St is expecting 1.08 EPS for $PBH Q2 [Reporting 11/07 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

allstarcharts Posted - 10/27/24

Mid-cap drug dealers $PBH

KCclean Posted - 10/26/24

$PBH nice look

ChristaBoarts Posted - 2 months ago

$PBH, a leader in personal care products, has strong brand recognition and continues to grow market share. Powered by FAAS

PenkeTrading Posted - 08/28/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Prestige Brand Holdings Inc. Is that bullish or bearish? $PBH #PBH #nyse #tradingsignals #technicalanalysis

Stocksrunner Posted - 3 months ago

Massive Moves Ahead! Are These Oversold Stocks Poised for a Comeback? $WRBY $WPP $TTGT $SHEN $PBH https://stocksrunner.com/posts?id=1012

epsguid Posted - 3 months ago

$PBH reported earnings of $0.90, consensus was $0.86 via @eWhispers #epsbeat http://eps.sh/d/pbh

Stock_Titan Posted - 3 months ago

$PBH Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results https://www.stocktitan.net/news/PBH/prestige-consumer-healthcare-inc-reports-first-quarter-fiscal-2025-wtb8osr64u5s.html

NVDAMillionaire Posted - 07/31/24

$PBH Prestige Consumer Healthcare Inc. (NYSE:PBH) – A Resilient Portfolio of Leading Healthcare Brands Driving Consistent Cash Flow Generation http://beyondspx.com/2024/07/30/prestige-consumer-healthcare-inc-nysepbh-a-resilient-portfolio-of-leading-healthcare-brands-driving-consistent-cash-flow-generation/

falconfly1 Posted - 4 months ago

$EYEN $SNY and $ROIV and $GRTS and $PBH What is new and opportunity in $EYEN? 1 - Insider bought 1.5 million shares in July and paid 1 Million dollars 2 - Vanguard biggest institution in the world bought 5 million dollars for a call option 3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company. 4 - Second FDA's strongest eyedrop sales start the first of August and are expected to generate 15 to 40 million per quarter. 5 - 8 or 9 August earnings call, and it should be good. 6 - MicroPine and MicroLine are unmet need eyedrops for children and the result is coming in Q4 2024.

Stock_Titan Posted - 4 months ago

$PBH Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results https://www.stocktitan.net/news/PBH/prestige-consumer-healthcare-to-release-fiscal-2025-first-quarter-1evdwza48gxd.html

wha1e Posted - 5 months ago

DA Davidson upgraded Prestige Consumer to Buy from Neutral with a price target of $93, up from $65. After having met with management, the firm believes the company can make their guidance and that the Clear Eyes supply chain issues are temporary. $PBH

Aigner_Andreas Posted - 5 months ago

TD SELL $PBH at 66.18, Supp 62.62 Resis 66.67 R6 HiLo 52% T1Y 67 strong_buy 1.5 DIV N/A #Prestige B #stocks #trading #finance #market

Thestocktraderhubzee Posted - 05/22/24

WATCHLIST MAY 22 2024 $SHCR Canaccord Genuity Maintains Buy on Sharecare, Maintains $2 Price Target $PBH Canaccord Genuity Maintains Buy on Prestige Consumer, Maintains $80 Price Target $INTU Wells Fargo Maintains Overweight on Intuit, Raises Price Target to $750 $ALB Scotiabank Downgrades Albemarle to Sector Perform, Lowers Price Target to $135 $SCCO Scotiabank Maintains Sector Underperform on Southern Copper, Lowers Price Target to $54

Thestocktraderhubzee Posted - 6 months ago

WATCHLIST MAY 17 2024 $MMM Vertical Research Upgrades 3M to Buy, Raises Price Target to $140 $GSL Jefferies Maintains Buy on Global Ship Lease, Raises Price Target to $29 $PBH DA Davidson Maintains Neutral on Prestige Consumer, Maintains $65 Price Target $SONN EF Hutton Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $7 $VKTX Raymond James Upgrades Viking Therapeutics to Strong Buy, Raises Price Target to $116

Ollip Posted - 6 months ago

@cubie $PBH was the play but didn’t touch because of low volume

briefingcom Posted - 6 months ago

Gapping down in reaction to earnings/guidance: $DLO -30.7% $PBH -7.6% $BOOT -6.5% $NUVB -3%

Ollip Posted - 6 months ago

@Delu_and_Sons @Cipty $PBH is the one I missed

Stocksrunner Posted - 6 months ago

Earnings Rundown: $TCON $SKYX $IPW announced Q1 2024 earnings transcripts, providing insights into their performance. $PBH reported a 3.1% YoY revenue decline in Q4. $DPRO $ICMB topped earnings estimates.

Estimize Posted - 6 months ago

$PBH misses the Estimize EPS Consensus by 14c and the Estimize Revenue Consensus by $12.50M. Reports FQ4 earnings of $1.02 EPS and $276... http://www.estimize.com/pbh/fq4-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

mikesterz7 Posted - 6 months ago

$PBH Earnings Key Financial Results Revenue: CA$1.46b (up 2.2% from 1Q 2023). Net income: CA$6.30m (up 6.8% from 1Q 2023). Profit margin: 0.4% (in line with 1Q 2023). EPS: CA$0.14 (up from CA$0.13 in 1Q 2023).

epsguid Posted - 6 months ago

$PBH reported earnings of $1.02, consensus was $1.14 via @eWhispers #epsmiss http://eps.sh/d/pbh

contangoz Posted - 6 months ago

down guidance $pbh

DonCorleone77 Posted - 6 months ago

$PBH Prestige Consumer sees FY25 EPS $4.40-$4.46, consensus $4.62 Sees FY25 revenue $1.125B-$1.140B, consensus $1.16B. Ron Lombardi, CEO, stated, "Managing a wide range of suppliers is a crucial operating element of our business model where we've operated successfully over the long-term under the objective of securing quality product on time. We have taken and continue to take numerous steps to enhance supply chain depth across our portfolio that will benefit our business over the long-term." "For FY25, we expect these supply chain challenges, largely concentrated in eye care, to persist through the first half but improve back to historic levels in the second half resulting in a FY25 organic revenue growth outlook of approximately 1%. We anticipate a similar earnings acceleration that results in approximate 5% to 6% EPS growth for the full fiscal year, driven by a combination of supply improvement as conditions resolve, gross margin expansion, and lower interest expense thanks to our strong cash generation." "We have evolved and strengthened our business profile over time with a portfolio of leading and diverse brands, an emphasis on expanding and diversifying our retailer and supplier base, and focus on disciplined capital allocation that has resulted in lower leverage. We remain focused on the execution of our business model and long-term brand-building, which underpin our long-term success and create shareholder value," Mr. Lombardi concluded.